WuXi XDC Cayman Inc
WuXi XDC Cayman Inc., a prominent player in the biopharmaceutical industry, is headquartered in China (CN) and operates extensively across Asia and North America. Founded in 2021, the company has quickly established itself as a leader in contract development and manufacturing services (CDMO), focusing on advanced therapies and biologics. WuXi XDC offers a unique suite of services, including process development, analytical testing, and commercial manufacturing, tailored to meet the specific needs of its clients. The company’s commitment to innovation and quality has positioned it as a trusted partner for pharmaceutical and biotechnology firms seeking to accelerate their product development timelines. With a strong emphasis on cutting-edge technology and regulatory compliance, WuXi XDC has achieved significant milestones, enhancing its reputation in the global market. Its strategic approach and dedication to excellence continue to drive its success in the competitive landscape of biopharmaceutical services.
DitchCarbon Score
How does WuXi XDC Cayman Inc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
WuXi XDC Cayman Inc's score of 20 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
WuXi XDC Cayman Inc's reported carbon emissions
In 2023, WuXi XDC Cayman Inc reported significant carbon emissions totalling approximately 25,374,000 kg CO2e, with emissions evenly split between Scope 1 and Scope 2, each contributing the same amount. This total reflects the company's direct and indirect emissions from its operations and energy consumption. WuXi XDC has committed to long-term climate initiatives aimed at achieving net-zero emissions across all scopes by 2050. To support this goal, the company has implemented a comprehensive analysis using climate scenarios, including the Representative Concentration Pathways (RCP) 2.6, to identify and prioritise physical and transition risks associated with climate change. As part of its climate strategy, WuXi XDC is focused on reducing its carbon footprint and enhancing sustainability practices, aligning with industry standards for climate action. The company's commitment to these initiatives underscores its dedication to addressing climate change and reducing overall emissions in the coming decades.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2023 | |
|---|---|
| Scope 1 | 25,374,000 |
| Scope 2 | 25,374,000 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
WuXi XDC Cayman Inc is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
